Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Mario Sznol
Based on 56 articles published since 2009
(Why 56 articles?)
||||
Expertise Level
The expertise of Mario Sznol ranks in the
  • Top 0.07%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 56 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Sznol, Mario   ·   Sznol, M
Work Locations
Details
Most likely:    Yale University   Contact    
2018
  • Margaret K. Callahan, Michael A. Postow, Neil H. Segal, Alexander Lesokhin, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY · Harriet Kluger and Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, and Yale-New Haven Hospital, New Haven, CT · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · and Suba Krishnan, Rafia Bhore, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 29040030
  • Georgina V. Long, University of Sydney, and Royal North Shore Hospital · Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales · Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia · Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL · Jeffrey Infante, Tennessee Oncology · Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN · Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX · Adil Daud, University of California, San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA · Rene Gonzalez, University of Colorado, Denver, CO · Lynn Schuchter, University of Pennsylvania, Philadelphia, PA · William Sharfman, Sidney Kimmel Cancer Center, Baltimore, MD · Robert McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University, New Haven, CT · Suman Redhu, Eduard Gasal, and Bijoyesh Mookerjee, Novartis, East Hanover, NJ · Jeffrey Weber, New York University Langone Medical Center, New York, NY · and Keith T. Flaherty, Dana-Farber/Harvard Cancer Center, Boston, MA. · Pubmed 28991513
  • James Larkin, Royal Marsden NHS Foundation Trust, London · Paul Lorigan, The Christie National Health Service Foundation Trust, Manchester, United Kingdom · David Minor, California Pacific Medical Center Research Institute · Adil Daud, University of California San Francisco, San Francisco · Bartosz Chmielowski, University of California, Santa Monica, CA · Sandra D'Angelo, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · Jeffrey Weber, Perlmutter Cancer Center at New York University-Langone Medical Center, New York · Nikhil Khushalani, Roswell Park Cancer Institute, Buffalo, NY · Gerald Linette, Washington University, St. Louis, MO · Christopher D. Lao, University of Michigan, Ann Arbor, MI · Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT · Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT · Jeffrey Sosman, Northwestern University, Chicago, IL · Dana Walker, George Kong, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ · Bart Neyns, University Hospital, Vrije Universiteit Brussel, Brussels, Belgium · Michael Smylie, Cross Cancer Institute, Edmonton, Alberta · Wilson H. Miller Jr, Jewish General Hospital and Segal Cancer Centre, McGill University, Montreal, Quebc, Canada · Ralf Gutzmer, Medizinische Hochschule Hannover, Hannover · Jessica C. Hassel, Nationale Centrum für Tumorerkrankungen Heidelberg, Heidelberg · Dirk Schadendorf, University Hospital Essen, Essen, Germany · and Christoph Hoeller, Medical University of Vienna, Wien, Austria. · Pubmed 28671856
  • Department of Medicine. · Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. · Institute for Stem Cell Biology and Regenerative Medicine, and. · Department of Biomedical Data Science, Stanford University, Stanford, California, USA. · Department of Dermatology. · Yale Center for Analytic Sciences. · Yale Cancer Center, and. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 29309048
  • Perlmutter Cancer Center, NYU-Langone Medical Center New York, New York. · Smilow Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Biodesix Inc, Boulder, Colorado. · Pubmed 29208646
2017
  • From the Section of Medical Oncology, Yale University School of Medicine, New Haven, CT. · Pubmed 28114259
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Clinica Universidad de Navarra, Pamplona, Spain. · The Angeles Clinic and Research Institute, Los Angeles, California. · Aarhus University Hospital, Aarhus, Denmark. · Gustave Roussy and Paris-Sud University Villejuif, Villejuif, France. · Istituto Oncologico Veneto, Padua, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy. · University Hospital of Siena, Siena, Italy. · Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · Bristol-Myers Squibb, Princeton, New Jersey. · Stanford University School of Medicine, Stanford, California. · Yale Comprehensive Cancer Center, New Haven, Connecticut. · Stanford University School of Medicine, Stanford, California. · Pubmed 27756788
  • Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT · Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan · Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy · David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Celeste Lebbé, Université Paris Diderot, Paris · Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France · John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA · Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel · Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA · Jessica Hassel, University Hospital, Heidelberg, Germany · Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria · Winald Gerritsen, University of Queensland, St Lucia · Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes · Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia · Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands · John McCaffrey, Irish Clinical Oncology Research Group, Dublin · Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland · Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28915085
  • Department of Immunobiology, Yale University School of Medicine, New Haven, USA. · Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. · CIBERONC (Centro de Investigación Biomedica en Red de Cáncer). · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Comprehensive Cancer Center Section of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. · Department of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain. · Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Spain. · Department of Dermatology, Yale University School of Medicine, New Haven, USA. · Pubmed 28595336
  • Department of Pathology, BML116 Yale School of Medicine, 310 Cedar Street, PO Box 208023, 06520 New Haven, CT USA. · Section of Medical Oncology, Yale School of Medicine, New Haven, CT USA. · Pubmed 28331615
  • Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Biology, School of Health and Natural Sciences, University of Saint Joseph, West Hartford, Connecticut. · Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Dermatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 28223273
  • Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa, FL · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY · Suzanne L. Topalian, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Hewei Li, Ian M. Waxman, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ · Dirk Schadendorf, University of Essen, Essen, Germany · James Larkin, Royal Marsden National Health Service Foundation Trust, London, United Kingdom · Georgina V. Long, Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia · and Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif-Paris Sud, France. · Pubmed 28068177
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · James Larkin, Royal Marsden Hospital, London · Paul Lorigan, University of Manchester, Manchester, United Kingdom · Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris · Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France · Benjamin Brady, Cabrini Health, Melbourne, Australia · Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium · Henrik Schmidt, Århus University, Åarhus, Denmark · Jessica C. Hassel, University Hospital Heidelberg, Heidelberg · Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude · Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver · Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada · Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL · and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
2016
  • Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. Electronic address: · Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA. · University of Connecticut Health Center, Farmington, CT, USA. · Pubmed 27267608
2015
  • From the Section of Medical Oncology, Yale University School of Medicine, New Haven, CT (M.S.). · Pubmed 25482238
  • Division of Medical Oncology, Yale Comprehensive Cancer Center, Yale University, New Haven, CT. Electronic address: · Division of Medical Oncology, Yale Comprehensive Cancer Center, Yale University, New Haven, CT. · Pubmed 25965368
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
  • Program in Computational Biology and Bioinformatics, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. · Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA. · School of Public Health, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA. · Comprehensive Cancer Center Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA. · Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA. · Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 26214590
  • Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Biology, School of Health and Natural Sciences, University of Saint Joseph, West Hartford, Connecticut. · Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Neurosurgery and Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25788491
  • Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island. · Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Therapeutic Radiology, Yale Cancer Center, New Haven, Connecticut. · Section of Medical Oncology, Department of Internal Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island. Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25511377
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center · Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN · Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA · Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL · Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX · Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales · Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia · Omid Hamid, Angeles Clinic and Research Institute, Los Angeles · Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA · Lynn Schuchter, University of Pennsylvania Abramson Cancer Center · Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA · William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD · Robert R. McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO · and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • Patrick A. Ott and Anna C. Pavlick, New York University Cancer Institute, New York, NY · Omid Hamid and Peter D. Boasberg, The Angeles Clinic and Research Institute, Los Angeles, CA · Harriet Kluger and Mario Sznol, Yale Cancer Center, New Haven, CT · Kevin B. Kim and Patrick Hwu, University of Texas MD Anderson Cancer Center, Houston, TX · Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, and Thomas A. Davis, Celldex Therapeutics, Hampton, NJ. · Pubmed 25267741
  • Suzanne L. Topalian, William H. Sharfman, Julie R. Brahmer, Evan J. Lipson, Janis M. Taube, and Drew M. Pardoll, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Mario Sznol and Harriet M. Kluger, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · David F. McDermott, Beth Israel Deaconess Medical Center · Donald P. Lawrence, Massachusetts General Hospital Cancer Center · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Richard D. Carvajal, Memorial Sloan-Kettering Cancer Center, New York, NY · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · John D. Powderly, Carolina BioOncology Institute, Huntersville, NC · Philip D. Leming, The Christ Hospital Cancer Center, Cincinnati, OH · Igor Puzanov and Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · David C. Smith, University of Michigan, Ann Arbor, MI · and Jon M. Wigginton, Georgia D. Kollia, and Ashok Gupta, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 24590637
  • Yale Cancer Center, New Haven, CT. · Pubmed 24445760
2012
  • Department of Internal Medicine and Melanoma Unit, Yale Cancer Center, New Haven, CT 06520, USA. · Pubmed 22484191
2011
  • Melanoma Program, Yale Cancer Center, New Haven, CT 06520, USA. · Pubmed 21427556
2009
  • Yale Cancer Center, 333 Cedar Street, FMP #126, New Haven, CT 06525, USA. · Pubmed 19679015
2015
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2013
  • Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25184258
  • Deptartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, United States of America ; The Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 23840523
  • *Department of Pathology, Yale University School of Medicine †Department of Internal Medicine (Medical Oncology), Yale Cancer Center, New Haven, CT ‡Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA. · Pubmed 23632354
2012
  • Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 22842228
  • Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520-8056, USA. · Pubmed 22550243
2011
  • Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA. · Pubmed 21523734
  • Smilow Cancer Hospital at Yale-New Haven, New Haven, CT, USA. · Pubmed 21990407
  • Yale University School of Medicine, New Haven, CT, USA. · Pubmed 21543894
  • Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA. · Pubmed 21487066
  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA. · Pubmed 21119596
2010
  • Department of Dermatology, Yale University School of Medicine, New Haven, CT 06520, USA. · Pubmed 20630094
  • Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Pubmed 20149136
2009
  • Yale Cancer Center and Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA. · Pubmed 19737955
  • Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520-8059, USA. · Pubmed 19491193
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 19234609
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 56 total) written by Mario Sznol about Melanoma:

  • Combination Strategies PD-1/PD-L1 Antagonists. 2018
  • Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study. 2018
  • Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib. 2018
  • Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial. 2018
  • Early B cell changes predict autoimmunity following combination immune checkpoint blockade. 2018
  • A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic Melanoma. 2018
  • Challenges in Conducting Clinical Research on Patients With Advanced Melanoma. 2017
  • Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody. 2017
  • Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. 2017
  • Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients. 2017
Show List of Full Article Records
Google Searches

Learn more about Mario Sznol using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Yale University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Yale University
2018
  • Margaret K. Callahan, Michael A. Postow, Neil H. Segal, Alexander Lesokhin, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY · Harriet Kluger and Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, and Yale-New Haven Hospital, New Haven, CT · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · and Suba Krishnan, Rafia Bhore, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 29040030
  • Georgina V. Long, University of Sydney, and Royal North Shore Hospital · Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales · Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia · Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL · Jeffrey Infante, Tennessee Oncology · Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN · Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX · Adil Daud, University of California, San Francisco, San Francisco · Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA · Rene Gonzalez, University of Colorado, Denver, CO · Lynn Schuchter, University of Pennsylvania, Philadelphia, PA · William Sharfman, Sidney Kimmel Cancer Center, Baltimore, MD · Robert McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University, New Haven, CT · Suman Redhu, Eduard Gasal, and Bijoyesh Mookerjee, Novartis, East Hanover, NJ · Jeffrey Weber, New York University Langone Medical Center, New York, NY · and Keith T. Flaherty, Dana-Farber/Harvard Cancer Center, Boston, MA. · Pubmed 28991513
  • James Larkin, Royal Marsden NHS Foundation Trust, London · Paul Lorigan, The Christie National Health Service Foundation Trust, Manchester, United Kingdom · David Minor, California Pacific Medical Center Research Institute · Adil Daud, University of California San Francisco, San Francisco · Bartosz Chmielowski, University of California, Santa Monica, CA · Sandra D'Angelo, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · Jeffrey Weber, Perlmutter Cancer Center at New York University-Langone Medical Center, New York · Nikhil Khushalani, Roswell Park Cancer Institute, Buffalo, NY · Gerald Linette, Washington University, St. Louis, MO · Christopher D. Lao, University of Michigan, Ann Arbor, MI · Kenneth Grossmann, Huntsman Cancer Institute, Salt Lake City, UT · Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT · Jeffrey Sosman, Northwestern University, Chicago, IL · Dana Walker, George Kong, and Christine Horak, Bristol-Myers Squibb, Princeton, NJ · Bart Neyns, University Hospital, Vrije Universiteit Brussel, Brussels, Belgium · Michael Smylie, Cross Cancer Institute, Edmonton, Alberta · Wilson H. Miller Jr, Jewish General Hospital and Segal Cancer Centre, McGill University, Montreal, Quebc, Canada · Ralf Gutzmer, Medizinische Hochschule Hannover, Hannover · Jessica C. Hassel, Nationale Centrum für Tumorerkrankungen Heidelberg, Heidelberg · Dirk Schadendorf, University Hospital Essen, Essen, Germany · and Christoph Hoeller, Medical University of Vienna, Wien, Austria. · Pubmed 28671856
  • Department of Medicine. · Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. · Institute for Stem Cell Biology and Regenerative Medicine, and. · Department of Biomedical Data Science, Stanford University, Stanford, California, USA. · Department of Dermatology. · Yale Center for Analytic Sciences. · Yale Cancer Center, and. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 29309048
  • Perlmutter Cancer Center, NYU-Langone Medical Center New York, New York. · Smilow Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Massachusetts General Hospital Cancer Center, Boston, Massachusetts. · Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · Biodesix Inc, Boulder, Colorado. · Pubmed 29208646
2017
  • From the Section of Medical Oncology, Yale University School of Medicine, New Haven, CT. · Pubmed 28114259
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Clinica Universidad de Navarra, Pamplona, Spain. · The Angeles Clinic and Research Institute, Los Angeles, California. · Aarhus University Hospital, Aarhus, Denmark. · Gustave Roussy and Paris-Sud University Villejuif, Villejuif, France. · Istituto Oncologico Veneto, Padua, Italy. · Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy. · University Hospital of Siena, Siena, Italy. · Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania. · Bristol-Myers Squibb, Princeton, New Jersey. · Stanford University School of Medicine, Stanford, California. · Yale Comprehensive Cancer Center, New Haven, Connecticut. · Stanford University School of Medicine, Stanford, California. · Pubmed 27756788
  • Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT · Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan · Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy · David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Celeste Lebbé, Université Paris Diderot, Paris · Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France · John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA · Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel · Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA · Jessica Hassel, University Hospital, Heidelberg, Germany · Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria · Winald Gerritsen, University of Queensland, St Lucia · Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes · Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia · Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands · John McCaffrey, Irish Clinical Oncology Research Group, Dublin · Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland · Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28915085
  • Department of Immunobiology, Yale University School of Medicine, New Haven, USA. · Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. · CIBERONC (Centro de Investigación Biomedica en Red de Cáncer). · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Comprehensive Cancer Center Section of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA. · Department of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain. · Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Spain. · Department of Dermatology, Yale University School of Medicine, New Haven, USA. · Pubmed 28595336
  • Department of Pathology, BML116 Yale School of Medicine, 310 Cedar Street, PO Box 208023, 06520 New Haven, CT USA. · Section of Medical Oncology, Yale School of Medicine, New Haven, CT USA. · Pubmed 28331615
  • Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Biology, School of Health and Natural Sciences, University of Saint Joseph, West Hartford, Connecticut. · Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Dermatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 28223273
  • Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa, FL · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY · Suzanne L. Topalian, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Hewei Li, Ian M. Waxman, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ · Dirk Schadendorf, University of Essen, Essen, Germany · James Larkin, Royal Marsden National Health Service Foundation Trust, London, United Kingdom · Georgina V. Long, Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia · and Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif-Paris Sud, France. · Pubmed 28068177
  • Sandra P. D'Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · James Larkin, Royal Marsden Hospital, London · Paul Lorigan, University of Manchester, Manchester, United Kingdom · Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris · Julie Charles, Grenoble University Hospital, Grenoble Alps University, Grenoble, France · Benjamin Brady, Cabrini Health, Melbourne, Australia · Bart Neyns, Universitair Ziekenhuis Brussel, Brussels, Belgium · Henrik Schmidt, Århus University, Åarhus, Denmark · Jessica C. Hassel, University Hospital Heidelberg, Heidelberg · Peter Mohr, Elbe Kliniken Buxtehude, Buxtehude · Martin Kaatz, SRH Waldklinikum Gera, University Hospital Jena, Jena, Germany · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Kerry J. Savage, BC Cancer Agency, University of British Columbia, Vancouver · Wilson H. Miller Jr, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, Canada · Ivan Marquez-Rodas, Hospital General Universitario Gregorio Marañón, Madrid, Spain · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Jeffrey S. Weber, Moffitt Cancer Center, Tampa, FL · and Mary Ruisi and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 28056206
2016
  • Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. Electronic address: · Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. · New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA. · University of Connecticut Health Center, Farmington, CT, USA. · Pubmed 27267608
2015
  • From the Section of Medical Oncology, Yale University School of Medicine, New Haven, CT (M.S.). · Pubmed 25482238
  • Division of Medical Oncology, Yale Comprehensive Cancer Center, Yale University, New Haven, CT. Electronic address: · Division of Medical Oncology, Yale Comprehensive Cancer Center, Yale University, New Haven, CT. · Pubmed 25965368
  • Moffitt Cancer Center, Tampa, FL, USA. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · California Pacific Center for Melanoma Research, San Francisco, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Medizinische Hochschule Hannover, Hannover, Germany. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Medical University of Vienna, Vienna, Austria. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · University of Michigan, Ann Arbor, MI, USA. · Washington University, St Louis, MO, USA. · Centre Hospitalier Universitaire de Lyon, Lyon, France. · Christie Hospital, Manchester, UK. · Huntsman Cancer Institute, Salt Lake City, UT, USA. · German Cancer Research Centre University Hospital, Heidelberg, Germany. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Yale Cancer Center, New Haven, CT, USA. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Elbe Kliniken Buxtehude, Buxtehude, Germany. · Department of Medicine, University of California, Los Angeles, CA, USA. · Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA. · Department of Oncology, Herlev Hospital, Copenhagen, Denmark. · Aix-Marseille University, Hopital de la Timone, Marseille, France. · Technische Universität München School of Medicine, II Medical Department, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Bristol-Myers Squibb, Braine-I'Alleud, Belgium. · Royal Marsden Hospital, London, UK. · Pubmed 25795410
  • Program in Computational Biology and Bioinformatics, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. · Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA. · School of Public Health, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA. · Comprehensive Cancer Center Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA. · Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA. · Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 26214590
  • Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Biology, School of Health and Natural Sciences, University of Saint Joseph, West Hartford, Connecticut. · Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Neurosurgery and Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25788491
  • Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island. · Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. · Department of Therapeutic Radiology, Yale Cancer Center, New Haven, Connecticut. · Section of Medical Oncology, Department of Internal Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island. Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25511377
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center · Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN · Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA · Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL · Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX · Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales · Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia · Omid Hamid, Angeles Clinic and Research Institute, Los Angeles · Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA · Lynn Schuchter, University of Pennsylvania Abramson Cancer Center · Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA · William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD · Robert R. McWilliams, Mayo Clinic, Rochester, MN · Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO · and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • Patrick A. Ott and Anna C. Pavlick, New York University Cancer Institute, New York, NY · Omid Hamid and Peter D. Boasberg, The Angeles Clinic and Research Institute, Los Angeles, CA · Harriet Kluger and Mario Sznol, Yale Cancer Center, New Haven, CT · Kevin B. Kim and Patrick Hwu, University of Texas MD Anderson Cancer Center, Houston, TX · Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, and Thomas A. Davis, Celldex Therapeutics, Hampton, NJ. · Pubmed 25267741
  • Suzanne L. Topalian, William H. Sharfman, Julie R. Brahmer, Evan J. Lipson, Janis M. Taube, and Drew M. Pardoll, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD · Mario Sznol and Harriet M. Kluger, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT · David F. McDermott, Beth Israel Deaconess Medical Center · Donald P. Lawrence, Massachusetts General Hospital Cancer Center · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · Richard D. Carvajal, Memorial Sloan-Kettering Cancer Center, New York, NY · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · John D. Powderly, Carolina BioOncology Institute, Huntersville, NC · Philip D. Leming, The Christ Hospital Cancer Center, Cincinnati, OH · Igor Puzanov and Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN · David C. Smith, University of Michigan, Ann Arbor, MI · and Jon M. Wigginton, Georgia D. Kollia, and Ashok Gupta, Bristol-Myers Squibb, Princeton, NJ. · Pubmed 24590637
  • Yale Cancer Center, New Haven, CT. · Pubmed 24445760
2012
  • Department of Internal Medicine and Melanoma Unit, Yale Cancer Center, New Haven, CT 06520, USA. · Pubmed 22484191
2011
  • Melanoma Program, Yale Cancer Center, New Haven, CT 06520, USA. · Pubmed 21427556
2009
  • Yale Cancer Center, 333 Cedar Street, FMP #126, New Haven, CT 06525, USA. · Pubmed 19679015
2015
  • From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom · Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy · Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.) · Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France · Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.) · Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.) · Department of Dermatology, University of Essen, Essen, Germany (D.S.) · University of Zürich Hospital, Zurich, Switzerland (R.D.) · Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie) · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.) · Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia · Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.) · Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.) · Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York · Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.) · Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc · Pubmed 26027431
2013
  • Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · Pubmed 25184258
  • Deptartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, United States of America ; The Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 23840523
  • *Department of Pathology, Yale University School of Medicine †Department of Internal Medicine (Medical Oncology), Yale Cancer Center, New Haven, CT ‡Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA. · Pubmed 23632354
2012
  • Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 22842228
  • Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520-8056, USA. · Pubmed 22550243
2011
  • Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA. · Pubmed 21523734
  • Smilow Cancer Hospital at Yale-New Haven, New Haven, CT, USA. · Pubmed 21990407
  • Yale University School of Medicine, New Haven, CT, USA. · Pubmed 21543894
  • Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA. · Pubmed 21487066
  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA. · Pubmed 21119596
2010
  • Department of Dermatology, Yale University School of Medicine, New Haven, CT 06520, USA. · Pubmed 20630094
  • Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA. · Pubmed 20149136
2009
  • Yale Cancer Center and Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510, USA. · Pubmed 19737955
  • Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520-8059, USA. · Pubmed 19491193
  • Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 19234609
Unspecified
2018
  • Department of Medicine. · Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. · Institute for Stem Cell Biology and Regenerative Medicine, and. · Department of Biomedical Data Science, Stanford University, Stanford, California, USA. · Department of Dermatology. · Yale Center for Analytic Sciences. · Yale Cancer Center, and. · Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA. · Pubmed 29309048
36 Other Locations Show
Yearly article counts 068184471134
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.